Back to All Events

Peripheral and Central Nervous System Drugs Advisory Committee

The committee will discuss biologics license application (BLA) 761178, for aducanumab solution for intravenous infusion, submitted by Biogen Inc., for the treatment of Alzheimer’s disease.

Earlier Event: November 2
Joint Meeting of the Anesthetic and Analgesic Drug Products Advisory Committee and the Drug Safety and Risk Management Advisory Committee
Later Event: December 10
Vaccines and Related Biological Products Advisory Committee